Literature DB >> 24188103

Predicting a complicated course of Clostridium difficile infection at the bedside.

M P M Hensgens1, O M Dekkers, A Goorhuis, S LeCessie, E J Kuijper.   

Abstract

Clostridium difficile infections (CDIs) are a common cause of antibiotic-associated diarrhoea and associated with CDI-related mortality in c. 10%. To date, there is no prediction model in use that guides clinicians to identify patients at high risk for complicated CDI. From 2006 to 2009, nine Dutch hospitals included hospitalized CDI patients in a prospective cohort. Potential predictors of a complicated course (ICU admission, colectomy or death due to CDI) were evaluated in uni- and multivariate logistic regression. A score was constructed that was internally validated by bootstrapping. Furthermore, a pilot external validation was performed. Twelve per cent of 395 CDI patients had a complicated course within 30 days after diagnosis. Age (≥85 years, OR 4.96; 50-84 years, 1.83), admission due to diarrhoea (OR 3.27), diagnosis at the ICU department (OR 7.03), recent abdominal surgery (OR 0.23) and hypotension (OR 3.25) were independent predictors of a complicated course. These variables were used to construct a prediction model. A score subsequently classified patients into high risk (39% with a complicated course), intermediate (16%), low (5%) or virtually no risk of experiencing a complicated course. The score performed well after internal validation (AUC 0.78) and a pilot external validation among 139 patients showed similar good performance (AUC 0.73). We present an easy-to-use, clinically useful risk score that is capable of categorizing CDI patients according to their outcome. Because classification is available at diagnosis, it could have major implications for treatment choice.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  CDI; Clostridium difficile infection; complicated course; mortality; prediction rule

Mesh:

Substances:

Year:  2013        PMID: 24188103     DOI: 10.1111/1469-0691.12391

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  21 in total

1.  Building a Better Crystal Ball for Predicting Complications of Clostridium difficile Infection.

Authors:  David M Aronoff
Journal:  Clin Infect Dis       Date:  2015-09-03       Impact factor: 9.079

2.  Evolving Strategies to Manage Clostridium difficile Colitis.

Authors:  Jessica A Bowman; Garth H Utter
Journal:  J Gastrointest Surg       Date:  2019-11-25       Impact factor: 3.452

3.  Predictors of severe outcomes in patients with Clostridium difficile infection from a Hispanic population.

Authors:  Laura Paláu-Dávila; Elvira Garza-González; Eva María Gutiérrez-Delgado; Adrián Camacho-Ortiz
Journal:  Indian J Gastroenterol       Date:  2016-12-17

4.  First recurrence of Clostridium difficile infection: clinical relevance, risk factors, and prognosis.

Authors:  T Larrainzar-Coghen; D Rodriguez-Pardo; M Puig-Asensio; V Rodríguez; C Ferrer; R Bartolomé; C Pigrau; N Fernández-Hidalgo; T Pumarola; B Almirante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-11       Impact factor: 3.267

5.  Faecal lactoferrin and calprotectin in patients with Clostridium difficile infection: a case-control study.

Authors:  F Barbut; C Gouot; N Lapidus; L Suzon; R Syed-Zaidi; V Lalande; C Eckert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-12       Impact factor: 3.267

6.  Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.

Authors:  D W Mulherin; A M Hutchison; G J Thomas; R A Hansen; D T Childress
Journal:  Infection       Date:  2014-08-17       Impact factor: 3.553

Review 7.  Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory Clostridium difficile Infection.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

Review 8.  Treatment of Severe and Fulminnant Clostridioides difficile Infection.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 9.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

10.  Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.

Authors:  Marie Pichenot; Rozenn Héquette-Ruz; Remi Le Guern; Bruno Grandbastien; Clément Charlet; Frédéric Wallet; Sophie Schiettecatte; Fanny Loeuillet; Benoit Guery; Tatiana Galperine
Journal:  Infection       Date:  2017-01-24       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.